Contact: Bill Schaller
Dana-Farber Cancer Institute
Caption: Levi Garraway, M.D., Ph.D., Dana-Farber Cancer Institute, Broad Institute, and his colleagues have identified two new mutations that collectively occur in 71 percent of malignant melanoma tumors. These highly "recurrent" mutations may be the most common mutations in melanoma cells found to date and are the first to be discovered in the vast regions of DNA in cancer cells that do not contain genetic instructions for making proteins.
Credit: Sam Ogden
Usage Restrictions: None
Related news release: Researchers discover new mutations driving malignant melanoma